Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

ABSTRACT:

Background

Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy.

Methods

We tested the hypothesis that the timing of ART initiation would significantly affect mortality among adults not previously exposed to antiretroviral drugs who had newly diagnosed tuberculosis and CD4+ T-cell counts of 200 per cubic millimeter or lower. After beginning the standard, 6-month treatment for tuberculosis, patients were randomly assigned to either earlier treatment (2 weeks after beginning tuberculosis treatment) or later treatment (8 weeks after) with stavudine, lamivudine, a

SUBMITTER: Blanc FX 

PROVIDER: S-EPMC4879711 | biostudies-literature | 2011 Oct

REPOSITORIES: biostudies-literature